The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Mertk Receptor Mutation Reduces Efferocytosis Efficiency and Promotes Apoptotic Cell Accumulation and Plaque Necrosis in Atherosclerotic Lesions of Apoe −/− Mice
Open accessAbstract
Objective— Atherosclerotic plaques that are prone to disruption and acute thrombotic vascular events are characterized by large necrotic cores. Necrotic cores result from the combination of macrophage apoptosis and defective phagocytic clearance (efferocytosis) of these apoptotic cells. We previously showed that macrophages with tyrosine kinase-defective Mertk receptor (Mertk KD ) have a defect in phagocytic clearance of apoptotic macrophages in vitro. Herein we test the hypothesis that the Mertk KD mutation would result in increased accumulation of apoptotic cells and promote necrotic core expansion in a mouse model of advanced atherosclerosis. Methods and Results— Mertk KD ; Apoe −/− mice and control Apoe −/− mice were fed a Western-type diet for 10 or 16 weeks, and aortic root lesions were analyzed for apoptosis and plaque necrosis. We found that the plaques of the Mertk KD ; Apoe −/− mice had a significant increase in terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL)-positive apoptotic cells. Most importantly, there were more non-macrophage-associated apoptotic cells in the Mertk KD lesions, consistent with defective efferocytosis. The more advanced (16-week) Mertk KD ; Apoe −/− plaques were more necrotic, consistent with a progression from apoptotic cell accumulation to plaque necrosis in the setting of a defective efferocytosis receptor. Conclusion— In a mouse model of advanced atherosclerosis, mutation of the phagocytic Mertk receptor promotes the accumulation of apoptotic cells and the formation of necrotic plaques. These data are consistent with the notion that a defect in an efferocytosis receptor can accelerate the progression of atherosclerosis and suggest a novel therapeutic target to prevent advanced plaque progression and its clinical consequences.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conversely, mice lacking MERTK or expressing a constitutively inactive form of MERTK show larger plaque size and increased necrotic core area compared with control mice196,197.”
From Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities (2019) · cites this paper as [196]
In the citing paper
“The impaired ability of macrophage efferocytosis would enhance atherogenesis [139,140,141] and atherosclerotic plaque instability [142,143,144].”
From Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases (2020) · cites this paper as [143]
Citations
Cites
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Inflammation in Atherosclerosis
Libby, P. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.179705 · Cited by 3,796
Cardiovascular Medicine at the Turn of the Millennium: Triumphs, Concerns, and Opportunities
Braunwald, E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711063371906 · Cited by 1,426
Tabas, I., Williams, K. J., & Borén, J. (2007) · Circulation · doi:10.1161/circulationaha.106.676890 · Cited by 1,399
Self-citationPhagocytosis and clearance of apoptotic cells is mediated by MER
Scott, R. S., McMahon, E. J., Pop, S. M., Reap, E. A., Caricchio, R., Cohen, P. L., Earp, H. S., & Matsushima, G. K. (2001) · Nature · doi:10.1038/35075603 · Cited by 1,215
Taylor, P. R., Carugati, A., Fadok, V. A., Cook, H. T., Andrews, M., Carroll, M. C., Savill, J., Henson, P. M., Botto, M., & Walport, M. J. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.3.359 · Cited by 724
Clarke, M. C. H., Figg, N. L., Maguire, J. J., Davenport, A. P., Goddard, M. J., Littlewood, T. D., & Bennett, M. R. (2006) · Nature Medicine · doi:10.1038/nm1459 · Cited by 645
Consequences and Therapeutic Implications of Macrophage Apoptosis in Atherosclerosis
Tabas, I. A. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000184783.04864.9f · Cited by 641
Self-citationCohen, P. L., Caricchio, R., Abraham, V., Camenisch, T. D., Jennette, J. C., Roubey, R. A. S., Earp, H. S., Matsushima, G. K., & Reap, E. A. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20012094 · Cited by 637
Consequences of cellular cholesterol accumulation: basic concepts and physiological implications
Tabas, I. A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16452 · Cited by 608
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 357
Pastore, M., Grimaudo, S., Pipitone, R. M., Lori, G., Raggi, C., Petta, S., & Marra, F. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00604 · Cited by 31
Role of Apoptotic Cell Clearance in Pneumonia and Inflammatory Lung Disease
Zheng, D. J., Taka, M. A., & Heit, B. (2021) · Pathogens · doi:10.3390/pathogens10020134 · Cited by 32
Thorp, E. B. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00039 · Cited by 31
Self-citationShedding Light on Impaired Efferocytosis and Nonresolving Inflammation
Novak, M. L., & Thorp, E. B. (2013) · Circulation Research · doi:10.1161/circresaha.113.301583 · Cited by 32
Self-citationShi, H., Wang, X., Sloas, C., Gerlach, B., Yurdagul, A., Moore, M. P., Jung, E. J., Mirshahi, F., Ronzoni, L., Sanyal, A. J., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adv2106 · Cited by 30
Self-citationPlasma receptor tyrosine kinase RET in pulmonary arterial hypertension diagnosis and differentiation
Säleby, J., Bouzina, H., Ahmed, S., Lundgren, J., & Rådegran, G. (2019) · ERJ Open Research · doi:10.1183/23120541.00037-2019 · Cited by 32
Reduction in CD16/CD56 and CD16/CD3/CD56 Natural Killer Cells in Coronary Artery Disease
Jabir, N. R., Firoz, C. K., Ahmed, F., Kamal, M. A., Hindawi, S., Damanhouri, G. A., Almehdar, H. A., & Tabrez, S. S. M. (2017) · Immunological Investigations · doi:10.1080/08820139.2017.1306866 · Cited by 30
The diverse roles of macrophages in metabolic inflammation and its resolution
Ray, A. G., Odum, O., Wiseman, D., & Weinstock, A. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1147434 · Cited by 31
Signalling from dead cells drives inflammation and vessel remodelling
Bennett, M. R., Yu, H., & Clarke, M. C. H. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.01.006 · Cited by 29
Hydroxyoctadecadienoic Acids Regulate Apoptosis in Human THP‐1 Cells in a PPARγ‐Dependent Manner
Vangaveti, V., Shashidhar, V., Rush, C. M., Malabu, U. H., Rasalam, R. R., Collier, F., Baune, B. T., & Kennedy, R. L. (2014) · Lipids · doi:10.1007/s11745-014-3954-z · Cited by 30
Current Understanding of the Mechanisms for Clearance of Apoptotic Cells—A Fine Balance
Hawkins, L., & Devitt, A. (2013) · Journal of Cell Death · doi:10.4137/jcd.s11037 · Cited by 28
FADD, Caspase-3, and Caspase-8 and Incidence of Coronary Events
Xue, L., Borné, Y., Mattisson, I. Y., Wigren, M., Melander, O., Ohro-Melander, M., Bengtsson, E., Fredrikson, G. N., Nilsson, J. Å., & Engström, G. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.308995 · Cited by 28
Manickam, V., Dhawan, U. K., Singh, D., Gupta, M., & Subramanian, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.888300 · Cited by 28
Tackling inflammation in atherosclerosis: Are we there yet and what lies beyond?
Bhattacharya, P., Kanagasooriyan, R., & Subramanian, M. (2022) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2022.102283 · Cited by 31
Zhao, M., Zheng, Z., Yin, Z., Zhang, J., Qin, J., Wan, J., & Wang, M. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106832 · Cited by 26
Recent Advances in the Role of Immunity in Atherosclerosis
Fredman, G., & Spite, M. R. (2013) · Circulation Research · doi:10.1161/circresaha.113.302986 · Cited by 26
Lewis, M., Malik, T. H., Fossati‐Jimack, L., Carassiti, D., Cook, H. T., Haskard, D. O., & Botto, M. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34451 · Cited by 26
Clarke, M. C. H., & Bennett, M. R. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.179903 · Cited by 26
Efferocytosis: the resolution of inflammation in cardiovascular and cerebrovascular disease
Zhang, B., Zou, Y., Yuan, Z., Jiang, K., Zhang, Z., Chen, S., Zhou, X., Wu, Q., & Zhang, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1485222 · Cited by 30
Adipose triglyceride lipase in immune response, inflammation, and atherosclerosis
Radović, B., Aflaki, E., & Kratky, D. (2012) · Biological Chemistry · doi:10.1515/hsz-2012-0192 · Cited by 25
Having an Old Friend for Dinner: The Interplay between Apoptotic Cells and Efferocytes
Lam, A. L., & Heit, B. (2021) · Cells · doi:10.3390/cells10051265 · Cited by 22
Liang, S., Sun, Q., Du, Z., Ren, X., Xu, Q., Sun, Z., & Duan, J. (2022) · Nanotoxicology · doi:10.1080/17435390.2022.2083995 · Cited by 24
Antibodies in action: the role of humoral immunity in the fight against atherosclerosis
Taylor, J. A., Hutchinson, M. A., Gearhart, P. J., & Maul, R. W. (2022) · Immunity & Ageing · doi:10.1186/s12979-022-00316-6 · Cited by 24
Qin, W., Lu, Y., Zhan, C., Shen, T., Dou, L., Man, Y., Wang, S., Xiao, C., Bian, Y., & Li, J. (2011) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-011-6347-z · Cited by 24
Rab17 mediates intermixing of phagocytosed apoptotic cells with recycling endosomes
Yin, C., Argintaru, D., & Heit, B. (2017) · Small GTPases · doi:10.1080/21541248.2017.1308852 · Cited by 24
Liao, J., Xie, Y., Lin, Q., Yang, X., An, X., Xia, Y., Du, J., Wang, F., & Li, H. (2019) · The Journal of Pathology · doi:10.1002/path.5368 · Cited by 24
Pleiotropic role of growth arrest-specific gene 6 in atherosclerosis
Tjwa, M., Moons, L., & Lutgens, E. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328330982e · Cited by 24
Diabetes mellitus and apoptosis: inflammatory cells
Ryan, A., Murphy, M., Godson, C., & Hickey, F. B. (2009) · APOPTOSIS · doi:10.1007/s10495-009-0340-z · Cited by 22
Immune Modulation of Vascular Resident Cells by Axl Orchestrates Carotid Intima-Media Thickening
Gerloff, J., & Korshunov, V. A. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.01.036 · Cited by 23
Immune system and atherosclerosis: Hostile or friendly relationship
Razeghian‐Jahromi, I., Akhormeh, A. K., Razmkhah, M., & Zibaeenezhad, M. J. (2022) · International Journal of Immunopathology and Pharmacology · doi:10.1177/03946320221092188 · Cited by 22
Frodermann, V., van Puijvelde, G. H. M., Wierts, L., Lagraauw, H. M., Foks, A. C., van Santbrink, P. J., Bot, I., Kuiper, J., & de Jager, S. C. A. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401843 · Cited by 22
The dynamic lives of macrophage and dendritic cell subsets in atherosclerosis
Taghavie-Moghadam, P. L., Butcher, M. J., & Galkina, E. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12392 · Cited by 21
Wang, X., Liu, Y., Zhang, S., Ouyang, X., Wang, Y., Jiang, Y., & An, N. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15430 · Cited by 23
Selective macrophage ascorbate deficiency suppresses early atherosclerosis
Babaev, V. R., Whitesell, R. R., Li, L., Linton, M. F., Fazio, S., & May, J. M. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.10.702 · Cited by 21
Macrophage mediators and mechanisms in cardiovascular disease
Schelemei, P., Wagner, E., Picard, F. S. R., & Winkels, H. (2024) · The FASEB Journal · doi:10.1096/fj.202302001r · Cited by 23
Jarr, K.-U., Kojima, Y., Weissman, I. L., & Leeper, N. J. (2022) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.122.317049 · Cited by 21
Duan, L., Zhao, Y., Jia, J., Chao, T., Wang, H., Liang, Y., Lou, Y., Zheng, Q., & Wang, H. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166698 · Cited by 20
Kayashima, Y., Makhanova, N., Matsuki, K., Tomita, H., Bennett, B. J., & Maeda, N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117478 · Cited by 20
Hosseini, H., Li, Y., Kanellakis, P., Cao, A. H., Tay, C., Peter, K., Bobik, A., Toh, B., & Kyaw, T. S. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.008447 · Cited by 19
Kayashima, Y., Makhanova, N., & Maeda, N. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.309522 · Cited by 19
Characteristics of B cell-associated gene expression in patients with coronary artery disease
Yan, W., Song, H., Jiang, J., Xu, W., Gong, Z., Duan, Q., LI, C., XIE, Y., & Wang, L. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5029 · Cited by 19
Novel tyrosine kinase signaling pathways
Batchu, S. N., & Korshunov, V. A. (2012) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3283503ce9 · Cited by 19
Effects of everolimus on macrophage-derived foam cell behavior
Hsu, S. H.-L., Koren, E., Chan, Y. F., Koscec, M., Sheehy, A. J., Kolodgie, F. D., Virmani, R., & Feder, D. (2014) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2014.05.007 · Cited by 18
Selective activation of CB2 receptor improves efferocytosis in cultured macrophages
Jiang, L.-S., Chen, Y., Huang, X., Yuan, A., Shao, Q., Pu, J., & He, B. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.07.013 · Cited by 20
Antagonistic Coevolution of MER Tyrosine Kinase Expression and Function
Evans, A. L., Blackburn, J. W. D., Taruc, K., Kipp, A., Dirk, B. S., Hunt, N. R., Barr, S. D., Dikeakos, J. D., & Heit, B. (2017) · Molecular Biology and Evolution · doi:10.1093/molbev/msx102 · Cited by 21
Physiological Roles of Apoptotic Cell Clearance: Beyond Immune Functions
Han, M., Ryu, G., Shin, S.-A., An, J., Kim, H., Park, D., Lee, D.-H., & Lee, C. S. (2021) · Life · doi:10.3390/life11111141 · Cited by 18
Cope, F. O., Abbruzzese, B. C., Sanders, J., Metz, W., Sturms, K., Ralph, D. A., Blue, M., Zhang, J., Bracci, P. M., Bshara, W., et al. (2015) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2015.11.007 · Cited by 17
Atherosclerosis in Different Vascular Locations Unbiasedly Approached with Mouse Genetics
Kayashima, Y., & Maeda-Smithies, N. (2020) · Genes · doi:10.3390/genes11121427 · Cited by 17
Lee, C.-H., Shieh, Y., Tsai, C., Hung, Y., Tsai, Y., & Lin, C.-Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079452 · Cited by 17
Quantitative Efferocytosis Assays
Evans, A. L., Blackburn, J. W. D., Yin, C., & Heit, B. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6581-6_3 · Cited by 17
Wasiak, S., Gilham, D., Tsujikawa, L. M., Halliday, C., Norek, K., Patel, R. G., McLure, K. G., Young, P. R., Gordon, A., Kulikowski, E., et al. (2016) · Data in Brief · doi:10.1016/j.dib.2016.07.047 · Cited by 17
The Fetal–Maternal Immune Interface in Uterus Transplantation
Iske, J., Elkhal, A., & Tullius, S. G. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.01.006 · Cited by 17
Heterogeneity of Macrophages in Atherosclerosis
Stremmel, C., Stark, K., & Schulz, C. (2019) · Thrombosis and Haemostasis · doi:10.1055/s-0039-1692665 · Cited by 16
O death where is thy sting? Immunologic tolerance to apoptotic self
Ravishankar, B., & McGaha, T. L. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1261-0 · Cited by 16
CD13 deficiency leads to increased oxidative stress and larger atherosclerotic lesions
Devarakonda, C. K. V., Pereira, F., Smith, J. D., Shapiro, L. H., & Ghosh, M. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.06.901 · Cited by 14
Small Molecule Activation of NAPE-PLD Enhances Efferocytosis by Macrophages
Zarrow, J. E., Alli-Oluwafuyi, A. O., Youwakim, C. M., Kim, K.-H., Jenkins, A. N., Suero, I. C., Jones, M. R., Mashhadi, Z., Mackie, K., Waterson, A. G., et al. (2023) · ACS Chemical Biology · doi:10.1021/acschembio.3c00401 · Cited by 14
Tallec, E. L., Bellamri, N., Lelong, M., Morzadec, C., Frenger, Q., Ballerie, A., Cazalets, C., Lescoat, A., Gros, F., & Lecureur, V. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1468821 · Cited by 16
Resolution Pharmacology: State-of-the-art and therapeutic landscape
Perretti, M., & Montero‐Melendez, T. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100097 · Cited by 15
A combination of secondhand cigarette smoke and Chlamydia pneumoniae accelerates atherosclerosis
Zhao, X., Bu, D.-X., Hayfron, K., Pinkerton, K. E., Bevins, C. L., Lichtman, A. H., & Wiedeman, J. A. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.02.005 · Cited by 13
Sun, Y., Gao, W. Z., Zhao, Y., Cao, W., Liu, Z., Cui, G., Tong, L., Lei, F., & Tang, B. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b00221 · Cited by 13
Frégeau, G., Sarduy, R., Elimam, H., Esposito, C. L., Mellal, K., Ménard, L., da Graça, S. D. L., Proulx, C., Zhang, J., Febbraio, M., et al. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.06.010 · Cited by 13
TAM receptors and their ligand-mediated activation: Role in atherosclerosis
Cai, B., & Kasikara, C. (2020) · International review of cytology · doi:10.1016/bs.ircmb.2020.09.001 · Cited by 13
Zhang, M., Wei, J., Sun, Y., He, C., Ma, S., Pan, X., & Zhu, X. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.03.008 · Cited by 15
Measuring Apoptotic Cell Engulfment (Efferocytosis) Efficiency
Gage, M. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9130-3_11 · Cited by 12
Leroy, V., Kollareth, D. J. M., Tu, Z., Valisno, J. A. C., Woolet-Stockton, M., Saha, B. K., Emtiazjoo, A. M., Rackauskas, M., Moldawer, L. L., Efron, P. A., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.179876 · Cited by 15
Xu, Y., Chen, J., Liu, Y., Zhang, G., Miao, G., Wu, J., Lu, K., Zhao, Y., Zhang, W., Zheng, L., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf523 · Cited by 11
Zhang, Z., Zhou, Y., Lv, Q., Gao, K., Li, Z., Miao, Q., & Shen, L. (2024) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/0113862073285562240305113728 · Cited by 11
Quantification of Efferocytosis by Single-cell Fluorescence Microscopy
Taruc, K., Yin, C., Wootton, D. G., & Heit, B. (2018) · Journal of Visualized Experiments · doi:10.3791/58149 · Cited by 11
Myeloid atg5 deletion impairs n-3 PUFA-mediated atheroprotection
Wang, Z., Sequeira, R. C., Zabalawi, M., Madenspacher, J. H., Boudyguina, E. Y., Ou, T., Nelson, J. M., Nie, Y., Zhao, Q., Fessler, M. B., et al. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.01.004 · Cited by 10
The Impaired Mechanism and Facilitated Therapies of Efferocytosis in Atherosclerosis
Wang, Z., Su, J. Y., Gong, F., Xue, L., & Su, Z. (2022) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001311 · Cited by 10
Subramanian, M., Proto, J. D., Matsushima, G. K., & Tabas, I. A. (2016) · Scientific Reports · doi:10.1038/srep39111 · Cited by 11
Self-citationPathogenesis of Atherosclerosis
Shah, P. K. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6705-2_21 · Cited by 10
MERTK coordinates efferocytosis by regulating integrin localization and activation
Dickson, B. H., Tasnim, T., Nicholson, R. A., Stanlake, N., Lam, A. L., Vrieze, A. M., Blythe, E. N., Dekaban, G. A., & Heit, B. (2026) · Journal of Cell Science · doi:10.1242/jcs.264792 · Cited by 11
Allosteric MAPKAPK2 inhibitors improve plaque stability in advanced atherosclerosis
Özcan, L., Kasikara, C., Yurdagul, A., Kuriakose, G., Hubbard, B. K., Serrano‐Wu, M. H., & Tabas, I. A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0246600 · Cited by 9
Self-citationZhang, H., You, G., Yang, Q., Jin, G., Lv, G., Fan, L., Chen, Y., Li, H., Yi, S., Li, H., et al. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167130 · Cited by 9
Koga, J., Umezu, R., Kondo, Y., Shirouzu, T., Orkhonselenge, N., Ueno, H., Katsuki, S., Matoba, T., Nishimura, Y., & Kataoka, M. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.118524 · Cited by 8
Ghorbanzadeh, S., Khojini, J. Y., Abouali, R., Alimardan, S., Zahedi, M., Tahershamsi, Z., Tajbakhsh, A., & Hayat, S. M. G. (2024) · Molecular Biotechnology · doi:10.1007/s12033-024-01222-6 · Cited by 7
Bajaj, R., Huang, X., Alves-Kotzev, N., Weyers, J. J., Levine, M. B., Garg, M., Mohamed, M., Maung, S., Parasa, R., Çap, M., et al. (2026) · Cardiovascular Research · doi:10.1093/cvr/cvaf281 · Cited by 7
ILRUN Promotes Atherosclerosis Through Lipid-Dependent and Lipid-Independent Factors
Bi, X., Stankov, S. G., Lee, P. C., Wang, Z., Wu, X., Li, L., Ko, Y.-A., Cheng, L., Zhang, H., Hand, N. J., et al. (2022) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.121.317156 · Cited by 7
Acid sphingomyelinase, autophagy, and atherosclerosis
Luft, F. C. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1134-5 · Cited by 7
Zhao, Q., Wang, Z., Meyers, A. K., Madenspacher, J. H., Zabalawi, M., Zhang, Q., Boudyguina, E. Y., Hsu, F., McCall, C. E., Furdui, C. M., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.777098 · Cited by 6
MERTK in the rat trigeminal system: a potential novel target for cluster headache?
Edvinsson, J. C. A., Ran, C., Olofsgård, F. J., Steinberg, A., Edvinsson, L. I., & Belin, A. C. (2024) · The Journal of Headache and Pain · doi:10.1186/s10194-024-01791-6 · Cited by 6
Post-translational modifications of the ligands: Requirement for TAM receptor activation
Geng, K. (2020) · International review of cytology · doi:10.1016/bs.ircmb.2020.09.002 · Cited by 7
Macrophage cannibalism: efferocytosis in atherosclerosis
Baxter, A. A., Poon, I. K. H., & Karunakaran, D. (2025) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000001010 · Cited by 5
Wang, H., Li, Y., Zhang, L., Lü, M., Li, C., & Li, Y. (2025) · Current Atherosclerosis Reports · doi:10.1007/s11883-025-01285-z · Cited by 6
Beydoun, N., & Feinstein, M. J. (2022) · Current Heart Failure Reports · doi:10.1007/s11897-022-00560-3 · Cited by 5
Macrophage efferocytosis is controlled by epigenetic modifications mediated by RBPJPreprint
Sadaf, S., Zhang, X., Lei, L., Shen, J., Jamal, I., Modugu, G., & Dutta, P. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.10.681723 · Cited by 8
Han, Y., Jin, S.-W., Pan, X., & Zhang, H. (2024) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2024.10.003 · Cited by 4
Redefining Macrophage Heterogeneity in Atherosclerosis: A Focus on Possible Therapeutic Implications
Kanuri, B., Maremanda, K. P., Chattopadhyay, D., Essop, M. F., Lee, M. K. S., Murphy, A. J., & Nagareddy, P. R. (2025) · Comprehensive physiology · doi:10.1002/cph4.70008 · Cited by 6
Impaired CAMK4 Activity Limits Atherosclerosis and Reprograms Myelopoiesis
Gonzalez, A. L., Youwakim, C. M., Leake, B. F., Fuller, K., Rahman, S. M. J., Dungan, M. M., Gu, K., Bonin, J. L., Cavnar, A. B., Michell, D. L., et al. (2025) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.125.322530 · Cited by 4
Macrophages Are Critical Inducers of Bleomycin-Induced Fibrosis in a Systemic Scleroderma Model
Baffert, B., Schneider, K., Wetzel, A., Zuffo, L. D., Chagué, C., Mitifiot, E., Bonnefoy, F., Kuźniewska, A., Saas, P., Bamoulid, J., et al. (2026) · American Journal Of Pathology · doi:10.1016/j.ajpath.2025.09.009 · Cited by 4
Kavanagh, M. E., del Real, I. H., Priéto, I., Alvarez-Moreno, R., Egido, J., López‐Franco, Ó., Lázaro, I., & Gómez‐Guerrero, C. (2026) · Cardiovascular Diabetology · doi:10.1186/s12933-026-03121-3 · Cited by 4
Fine-tuning inflammation-resolution programs
Fredman, G., Sadhu, S., & Rymut, N. (2016) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000351 · Cited by 4
A MERry Response After Myocardial Infarction
Arandjelovic, S., & Ravichandran, K. S. (2013) · Circulation Research · doi:10.1161/circresaha.113.302155 · Cited by 4
Scolaro, B., Brown, E. J., Krautter, F., Petitjean, M., Donahoe, C., Pena, S., Garabedian, M. L., Nikain, C. A., Laskou, M., Tufanlı, Ö., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.07.539777 · Cited by 4
Macrophage efferocytosis in cardiovascular disease: mechanisms and therapeutic implications
Gupta, N., Liu, Y., & Cai, B. (2026) · ImmunoHorizons · doi:10.1093/immhor/vlag002 · Cited by 3
A bibliometric analysis of efferocytosis in cardiovascular diseases from 2001 to 2022
Hu, L., Lv, Z., Gu, Y., Zheng, T., Kong, Y., & Mao, W. (2023) · Medicine · doi:10.1097/md.0000000000034366 · Cited by 3
Lemke, G. (2015) · Springer eBooks · doi:10.1007/978-3-319-11888-8_2 · Cited by 3
Atherogenesis and Vascular Biology
Toth, P. P. (2020) · Contemporary cardiology · doi:10.1007/978-3-030-56514-5_2 · Cited by 3
Phosphorylation Regulation by Kinases and Phosphatases in Atherosclerosis
Elliott, K. J., & Eguchi, S. (2015) · Atherosclerosis · doi:10.1002/9781118828533.ch35 · Cited by 3
Metadata
- Authors
- Thorp, E., Cui, D., Schrijvers, D. M., Kuriakose, G., & Tabas, I.
- Affiliations
- Columbia University (US)
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2008-08
- Volume
- 28
- Issue
- 8
- Pages
- 1421-1428
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- PMC
- PMC2575060
- OpenAlex
- W2122693935
- Cited by
- 357
- References
- 38
- Citations by year
- 2026: 22 · 2025: 16 · 2024: 25 · 2023: 13 · 2022: 19 · 2021: 21 · 2020: 24 · 2019: 22 · 2018: 25 · 2017: 26 · 2016: 22 · 2015: 19 · 2014: 19 · 2013: 23 · 2012: 19
- FWCI
- 5.84
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL-75662, P01HL054591, R01HL075662, HL 54591)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- efferocytosis, macrophage apoptosis, ApoE-deficient mice, plaque progression, Western diet, aortic root lesions, therapeutic target
- MeSH terms
- c-Mer Tyrosine Kinase, Animals, Aorta, Apolipoproteins E, Disease Models, Animal, Foam Cells, Male, Mutation, Phagocytosis, Proto-Oncogene Proteins, Apoptosis, Mice, Knockout, In Situ Nick-End Labeling, Receptor Protein-Tyrosine Kinases, Atherosclerosis, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review